ATE349225T1 - Apo b, annexin v und tubulin: medizinische und diagnostische verwendung und verwendung zur purifikation von hcv - Google Patents
Apo b, annexin v und tubulin: medizinische und diagnostische verwendung und verwendung zur purifikation von hcvInfo
- Publication number
- ATE349225T1 ATE349225T1 AT98959859T AT98959859T ATE349225T1 AT E349225 T1 ATE349225 T1 AT E349225T1 AT 98959859 T AT98959859 T AT 98959859T AT 98959859 T AT98959859 T AT 98959859T AT E349225 T1 ATE349225 T1 AT E349225T1
- Authority
- AT
- Austria
- Prior art keywords
- hcv
- tubulin
- annexin
- proteins
- apo
- Prior art date
Links
- 102000004243 Tubulin Human genes 0.000 title abstract 2
- 108090000704 Tubulin Proteins 0.000 title abstract 2
- 102000000412 Annexin Human genes 0.000 title 1
- 108050008874 Annexin Proteins 0.000 title 1
- 238000000746 purification Methods 0.000 title 1
- 102000003839 Human Proteins Human genes 0.000 abstract 3
- 108090000144 Human Proteins Proteins 0.000 abstract 3
- 241000711549 Hepacivirus C Species 0.000 abstract 2
- 102000004121 Annexin A5 Human genes 0.000 abstract 1
- 108090000672 Annexin A5 Proteins 0.000 abstract 1
- 101710095342 Apolipoprotein B Proteins 0.000 abstract 1
- 102100040202 Apolipoprotein B-100 Human genes 0.000 abstract 1
- 101710091045 Envelope protein Proteins 0.000 abstract 1
- 101710188315 Protein X Proteins 0.000 abstract 1
- 102100021696 Syncytin-1 Human genes 0.000 abstract 1
- 108010003533 Viral Envelope Proteins Proteins 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4718—Lipocortins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Marine Sciences & Fisheries (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97870178 | 1997-11-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE349225T1 true ATE349225T1 (de) | 2007-01-15 |
Family
ID=8231062
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98959859T ATE349225T1 (de) | 1997-11-06 | 1998-11-06 | Apo b, annexin v und tubulin: medizinische und diagnostische verwendung und verwendung zur purifikation von hcv |
Country Status (8)
Country | Link |
---|---|
US (1) | US6670114B1 (de) |
EP (1) | EP1028742B1 (de) |
JP (1) | JP2001522809A (de) |
AT (1) | ATE349225T1 (de) |
AU (1) | AU756303B2 (de) |
CA (1) | CA2305715A1 (de) |
DE (1) | DE69836758T2 (de) |
WO (1) | WO1999024054A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7091324B2 (en) | 1998-11-05 | 2006-08-15 | Board Of Trustees Of Leland Stanford Junior University | Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes |
EP1127170A4 (de) | 1998-11-05 | 2005-04-27 | Univ Leland Stanford Junior | Menschliche monoklonale antikörper gegen menschlichen pan-hepatitis c virus |
US6815160B1 (en) * | 1999-07-28 | 2004-11-09 | Chiron Corporation | Hepatitis C viral antigen immunoassay detection systems |
US20020160936A1 (en) * | 1999-09-29 | 2002-10-31 | Howard J. Worman | Hcv e2 protein binding agents for treatment of hepatitis c virus infection |
GB9927320D0 (en) | 1999-11-18 | 2000-01-12 | Chiron Spa | Exosome separation |
AU2002229581A1 (en) * | 2000-12-01 | 2002-06-11 | Innogenetics N.V. | Proteins binding hcv and their medical, diagnostic and purification use |
US7645739B2 (en) | 2001-02-21 | 2010-01-12 | Alavita Pharmaceuticals, Inc. | Modified annexin compositions and methods of using same |
US7635680B2 (en) | 2001-02-21 | 2009-12-22 | Alavita Pharmaceuticals, Inc. | Attenuation of reperfusion injury |
AU2002252035A1 (en) | 2001-02-21 | 2002-09-12 | Surromed, Inc. | Modified annexin proteins and methods for preventing thrombosis |
US7635676B2 (en) | 2001-02-21 | 2009-12-22 | Alavita Pharmaccuticals, Inc. | Modified annexin proteins and methods for their use in organ transplantation |
GB0329958D0 (en) | 2003-12-24 | 2004-01-28 | Univ Manchester | Treatment of viral infections |
ITMI20040891A1 (it) * | 2004-05-04 | 2004-08-04 | Ibsa Inst Biochimique Sa | Nuovo metodo per la partizione ed inattivazione di contaminanti virali e prionici |
GB0413001D0 (en) | 2004-06-10 | 2004-07-14 | Johnson & Johnson Medical Ltd | Diagnostic and prognostic |
US20060057591A1 (en) * | 2004-09-15 | 2006-03-16 | Canadian Blood Services | Method for preventing viral infection |
JP7432529B2 (ja) | 2018-05-30 | 2024-02-16 | プロメガ コーポレイション | 広域スペクトルキナーゼ結合剤 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3734015A1 (de) * | 1987-10-08 | 1989-04-20 | Behringwerke Ag | Diagnostisches mittel und verfahren zur bestimmung von apolipoprotein b |
US5206086A (en) * | 1987-10-13 | 1993-04-27 | University Of Rochester | Particle-stabilized epitopes for standardization and control of immunoassays |
US5187068A (en) * | 1989-06-09 | 1993-02-16 | Nicolae Luca | Method for determination of lipid moiety and apolipoprotein expressed epitope immunoreactivity on intact lipoprotein |
DE4206574C1 (en) * | 1992-03-02 | 1993-08-26 | Reiner Prof. Dr. 3400 Goettingen De Thomssen | Fractionation method of parts of hepatitis C virus - by concn. of complexes of virus parts and lipoprotein(s) having low densities useful in hepatitis C virus detection and distinction of variants |
WO1994001554A1 (en) * | 1992-07-08 | 1994-01-20 | N.V. Innogenetics S.A. | Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions |
DE69526636T3 (de) * | 1994-07-29 | 2006-11-23 | Innogenetics N.V. | Gereinigte hepatitis-c-virus hüllproteine zur diagnostischen und therapeutischen verwendung |
-
1998
- 1998-11-06 EP EP98959859A patent/EP1028742B1/de not_active Expired - Lifetime
- 1998-11-06 AU AU15610/99A patent/AU756303B2/en not_active Ceased
- 1998-11-06 WO PCT/EP1998/007107 patent/WO1999024054A1/en active IP Right Grant
- 1998-11-06 CA CA002305715A patent/CA2305715A1/en not_active Abandoned
- 1998-11-06 AT AT98959859T patent/ATE349225T1/de not_active IP Right Cessation
- 1998-11-06 DE DE69836758T patent/DE69836758T2/de not_active Expired - Lifetime
- 1998-11-06 JP JP2000520142A patent/JP2001522809A/ja not_active Withdrawn
-
2000
- 2000-05-05 US US09/564,951 patent/US6670114B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69836758D1 (de) | 2007-02-08 |
JP2001522809A (ja) | 2001-11-20 |
CA2305715A1 (en) | 1999-05-20 |
DE69836758T2 (de) | 2007-10-11 |
EP1028742A1 (de) | 2000-08-23 |
AU1561099A (en) | 1999-05-31 |
WO1999024054A1 (en) | 1999-05-20 |
US6670114B1 (en) | 2003-12-30 |
EP1028742B1 (de) | 2006-12-27 |
AU756303B2 (en) | 2003-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE349225T1 (de) | Apo b, annexin v und tubulin: medizinische und diagnostische verwendung und verwendung zur purifikation von hcv | |
DE69533855D1 (de) | UNTERBRECHUNG DER BINDUNG DER PROTEINE MDM2 UND p53 UND ENTSPRECHENDE THERAPEUTISCHE ANWENDUNG | |
DE69922958D1 (de) | Hcv hüllproteine partikel : verwendung für therapeutische impfung | |
EA199801044A1 (ru) | Модуляторы регенерации тканей | |
ATE368054T1 (de) | Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität | |
DE68919229D1 (de) | Hybride prokoagulierende proteine. | |
ES8500322A1 (es) | Un metodo de modificar un virus para conferirle una nueva funcion biologica. | |
ATE91630T1 (de) | Pharmazeutische zusammensetzung zur verhuetung oder heilung von durch den papillomavirus induzierten tumoren. | |
DE59109221D1 (de) | HCV-spezifische Peptide, Mittel dazu und ihre Verwendung | |
DK0737207T3 (da) | Inhibitorer for humant plasmin afledt af Kunitz-domæner | |
DE69942708D1 (de) | Virus enthaltende Zusammensetzungen und Methoden zur Konzentration von Viruspräparaten | |
DE60233955D1 (de) | Spezifische bindungsmittel von human angiopoietin-2 | |
DE69631544D1 (de) | Fettleibigkeitsprotein (ob) zur erhögung der mageren körpermasse | |
ATE373016T1 (de) | Induktion von immunologischer toleranz gegen einen therapeutischen antikörper durch varianten des therapeutischen antikörpers | |
DE69327755D1 (de) | Zusammensetzung zum Unterdrücken von Infektion und Wachstum des menschlichen Immunschwäche-Virus unter Verwendung eines eisenbindenden Proteins | |
DE60217326D1 (de) | Von neurofilamentproteinen abgeleitete peptide und deren medizinische verwendung | |
DE69737651D1 (de) | Cortistatin: neuropeptide, zusammensetzungen und methoden | |
DE69631443D1 (de) | Reagens zur untersuchung von viren-agglutination und kit zur untersuchung auf viren | |
DE59508137D1 (de) | Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine | |
DE69837148D1 (de) | Chimäre proteine zur behandlung von diabetes | |
DE50002164D1 (de) | Peptide zur inhibierung von hpv e6-proteinen | |
TR199801769T2 (xx) | D���k reg�lasyona diren�li C3 d�n��t�r�c�ler. | |
ATE286509T1 (de) | Interferon alpha/beta bindendes protein, seine herstellung und anwendung | |
DE60124523D1 (de) | Zusammensetzung einer Parvovirus VP1-Proteinvariante und eines arvovirus NS1-Proteins zur Induktion von Zytolyse | |
DE69629121D1 (de) | Verwendung eines 24 kD Proteins zur Behandlung und Diagnose einer HCV Infektion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |